Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Lewis

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
ACS Chemical Biology|April 12, 2016
Inhibition of Zinc-Dependent Histone Deacetylases with a Chemically Triggered ElectrophileZarko V Boskovic, Melissa M Kemp, Allyson M Freedy, et al.
ACS Medicinal Chemistry Letters|October 18, 2012
Macrocyclic Hedgehog Pathway Inhibitors: Optimization of Cellular Activity and Mode of Action StudiesChris Dockendorff, Marek M Nagiec, Michel Weïwer, et al.
ACS Medicinal Chemistry Letters|October 20, 2015
Indolinyl-Thiazole Based Inhibitors of Scavenger Receptor-BI (SR-BI)-Mediated Lipid TransportChris Dockendorff, Patrick W Faloon, Miao Yu, et al.
Cancer Cell|September 13, 2011
Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABLRaghuveer Singh Mali, Baskar Ramdas, Peilin Ma, et al.
Neuro-Oncology Advances|August 21, 2024
Velcrin molecular glues induce apoptosis in glioblastomas with high <i>PDE3A</i> and <i>SLFN12</i> expressionElisa Aquilanti, Silvia Goldoni, Andrew Baker, et al.
Structure (London, England : 1993)|November 21, 2017
Structural Basis for the Inhibitory Effects of Ubistatins in the Ubiquitin-Proteasome PathwayMark A Nakasone, Timothy A Lewis, Olivier Walker, et al.
Nature Biotechnology|December 23, 2008
Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapyJinyan Du, Paula Bernasconi, Karl R Clauser, et al.
Nature Chemical Biology|December 15, 2015
Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomicsLuc de Waal, Timothy A Lewis, Matthew G Rees, et al.
Cancer Discovery|October 15, 2025
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung CancerFranziska Siegel, Stephan Siegel, Kristýna Kotýnková, et al.
Nature Communications|July 17, 2021
Structure of PDE3A-SLFN12 complex reveals requirements for activation of SLFN12 RNaseColin W Garvie, Xiaoyun Wu, Malvina Papanastasiou, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
ACS Chemical Biology|April 12, 2016
Inhibition of Zinc-Dependent Histone Deacetylases with a Chemically Triggered ElectrophileZarko V Boskovic, Melissa M Kemp, Allyson M Freedy, et al.
ACS Medicinal Chemistry Letters|October 18, 2012
Macrocyclic Hedgehog Pathway Inhibitors: Optimization of Cellular Activity and Mode of Action StudiesChris Dockendorff, Marek M Nagiec, Michel Weïwer, et al.
ACS Medicinal Chemistry Letters|October 20, 2015
Indolinyl-Thiazole Based Inhibitors of Scavenger Receptor-BI (SR-BI)-Mediated Lipid TransportChris Dockendorff, Patrick W Faloon, Miao Yu, et al.
Cancer Cell|September 13, 2011
Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABLRaghuveer Singh Mali, Baskar Ramdas, Peilin Ma, et al.
Neuro-Oncology Advances|August 21, 2024
Velcrin molecular glues induce apoptosis in glioblastomas with high <i>PDE3A</i> and <i>SLFN12</i> expressionElisa Aquilanti, Silvia Goldoni, Andrew Baker, et al.
Structure (London, England : 1993)|November 21, 2017
Structural Basis for the Inhibitory Effects of Ubistatins in the Ubiquitin-Proteasome PathwayMark A Nakasone, Timothy A Lewis, Olivier Walker, et al.
Nature Biotechnology|December 23, 2008
Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapyJinyan Du, Paula Bernasconi, Karl R Clauser, et al.
Nature Chemical Biology|December 15, 2015
Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomicsLuc de Waal, Timothy A Lewis, Matthew G Rees, et al.
Cancer Discovery|October 15, 2025
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung CancerFranziska Siegel, Stephan Siegel, Kristýna Kotýnková, et al.
Nature Communications|July 17, 2021
Structure of PDE3A-SLFN12 complex reveals requirements for activation of SLFN12 RNaseColin W Garvie, Xiaoyun Wu, Malvina Papanastasiou, et al.
Pageof 5